Navigation Links
Amgen And Astellas Announce Japan Alliance
Date:5/28/2013

THOUSAND OAKS, Calif. and TOKYO, May 29, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN), the world's largest independent biotechnology company, and Astellas Pharma Inc. (Tokyo Stock Exchange: 4503, "Astellas"), a leading Tokyo-based global pharmaceutical company, today announced the companies have entered into a strategic alliance to provide new medicines to help address serious unmet medical needs of Japanese patients.

The alliance leverages the complementary capabilities of both companies through an innovative business model that combines Amgen's pipeline candidates with Astellas' deep knowledge of Japanese patient and physician needs, long-term commercial and regulatory experience, and strong presence as a leading company in Japan.

The first element of the alliance is a long-term collaboration between the two companies that will focus on the co-development and co-commercialization in Japan of five Amgen pipeline medicines. The five medicines, which include four biologics and one small molecule, are focused on the treatment of cardiovascular and bone diseases and cancer. The pipeline medicines range from early to late stages of development in Japan, with the first potential commercial launch expected as early as 2016.

The second element of the alliance is the establishment of a Tokyo-based joint venture company through which the companies will work together to enable Amgen to rapidly build on-the-ground capabilities in Japan. The joint venture will operate under the name Amgen Astellas BioPharma KK and will be led by Eiichi Takahashi , who will serve as general manager. Additional management roles will be appointed by Am
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Intelomed is pleased to announce that ... as the Vice President of Clinical Affairs. With over ... device industry, Kay,s experience in taking medical technology and ... to global expansion, is a valuable addition to the ... on our team, and I am confident her focused ...
(Date:8/26/2014)... Research and Markets has announced ... Report 2014 " report to their offering. ... is a professional and in-depth study on the current ... The report provides a basic overview of the industry ... glucose meter market analysis is provided for both the ...
(Date:8/26/2014)... DUBLIN , Aug. 26, 2014 ... "Global Intranasal Drug Delivery Market 2014-2018" report ... is a medical device used for the administration of ... nose and paranasal sinus such as allergic and non-allergic ... an ideal administrative route for needle-free vaccination and systematic ...
Breaking Medicine Technology:Mary Kay Deck joins Intelomed as Vice President of Clinical Affairs 2Global Glucose Meter Industry Report 2014 2Global Glucose Meter Industry Report 2014 3Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3
(Date:8/27/2014)... 2014 Aspirus Wausau Hospital today announced ... with Buzz™ Digital O.R. at Aspirus Wausau Hospital, in ... new operating rooms will be Buzz, a centralized surgical ... system supports planning, navigation, imaging and communications connectivity. ... intuitive software and hardware all controlled from the full ...
(Date:8/27/2014)... 26, 2014 (HealthDay News) -- Health care workers in ... to keep them safe from being infected with blood-borne ... shows. While the study was conducted before the ... its findings are confirmed in statistics released Monday by ... agency reported that an "unprecedented" number of health care ...
(Date:8/27/2014)... patients are 70 per cent more likely to continue ... they have a prescription in hand when discharged ... the Institute for Clinical Evaluative Sciences (ICES). , Using ... Ontarians were taking their medications one week, one year ... reveal the importance of simple interventions, such as giving ...
(Date:8/27/2014)... Hills, CA (PRWEB) August 27, 2014 Bedros ... camp franchise in the world, the leading fitness boot ... Spike TV’s Gym Rescue reality series. One thing he knows ... brand as a subject matter expert in the fitness business. ... to YouTube, he lays out a step-by-step instructional guide on ...
(Date:8/27/2014)... Phoenix, AZ (PRWEB) August 27, 2014 ... that serves the greater Phoenix metropolitan area and all ... client more than $160,000 on a $2 million settlement. ... tangible savings to those who have been injured through ... can be complex and time-consuming, however Hastings and Hastings ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 2Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 3Health News:A prescription for better stroke care 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 3
... has been released by Australian obesity experts that show gastric ... conference on obesity in Sydney there were three studies which ... in mortality rates in obese people who had the surgery. ... upper part of the stomach for the procedure to restrict ...
... a 4- to 5-point IQ advantage over women by adulthood. ... to 18-year-//olds on the Scholastic Assessment Test (SAT). ... because girls mature faster than boys. This is the reason ... ,145 items from the SAT were examined by a study ...
... of the opinion that eating nuts about twice a week might ... that was presented at the World Congress of Cardiology stated that ... would be around a small plate full might reduce the risk ... survey confirmed that eating a small quantity of the same kinds ...
... hang heavy with heart problems, going back at least two ... she hit age 50,// Catherine got nervous. ,A ... and perhaps those of others in her family tree. She ... causes her heart muscle to grow too thick. The extra ...
... Industry in China has placed on record the successful initial ... vaccine is said to operate in low doses, nearly one-third ... undertaken till date. The smaller doses are proven to be ... observed that just two 10-microgram doses of the Sinovac vaccine, ...
... Scottish Executive have announced their plans to offer dental students ... them in the NHS.// ,It has been explained ... given ?4,000 a year in return for a commitment of ... ,Lewis Macdonald, the deputy health minister, had announced the launch ...
Cached Medicine News:Health News:Greater g factor in men responsible for sex differences in general mental ability 2Health News:Greater g factor in men responsible for sex differences in general mental ability 3Health News:Fight Back Against Inherited Sudden-Death Heart Condition 2Health News:Fight Back Against Inherited Sudden-Death Heart Condition 3Health News:Fight Back Against Inherited Sudden-Death Heart Condition 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: